These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24057815)

  • 61. Differential effects of ondansetron and alpha-flupenthixol on responding for conditioned reward.
    Fletcher PJ; Higgins GA
    Psychopharmacology (Berl); 1997 Nov; 134(1):64-72. PubMed ID: 9399368
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine.
    Cagniard B; Sotnikova TD; Gainetdinov RR; Zhuang X
    J Neurogenet; 2014; 28(1-2):112-21. PubMed ID: 24673634
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An antihyperkinetic action by the serotonin 1A-receptor agonist osemozotan co-administered with psychostimulants or the non-stimulant atomoxetine in mice.
    Tsuchida R; Kubo M; Kuroda M; Shibasaki Y; Shintani N; Abe M; Köves K; Hashimoto H; Baba A
    J Pharmacol Sci; 2009 Mar; 109(3):396-402. PubMed ID: 19270432
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.
    Scarponi M; Bernardi G; Mercuri NB
    Eur J Neurosci; 1999 Feb; 11(2):593-8. PubMed ID: 10051759
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Do antidepressants affect motivation in conditioned place preference?
    Subhan F; Deslandes PN; Pache DM; Sewell RD
    Eur J Pharmacol; 2000 Nov; 408(3):257-63. PubMed ID: 11090642
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys.
    Spealman RD
    J Pharmacol Exp Ther; 1995 Oct; 275(1):53-62. PubMed ID: 7562595
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Noradrenergic signaling in the VTA modulates cocaine craving.
    Solecki WB; Szklarczyk K; Pradel K; Kwiatkowska K; Dobrzański G; Przewłocki R
    Addict Biol; 2018 Mar; 23(2):596-609. PubMed ID: 28635140
    [TBL] [Abstract][Full Text] [Related]  

  • 68. GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat.
    Baumann MH; Char GU; De Costa BR; Rice KC; Rothman RB
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1216-22. PubMed ID: 7996429
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain.
    Easton N; Steward C; Marshall F; Fone K; Marsden C
    Neuropharmacology; 2007 Feb; 52(2):405-14. PubMed ID: 17020775
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mixed D2/5-HT2A antagonism of cocaine-induced facilitation of brain stimulation reward.
    Tsibulsky VL; Grocki S; Dashevsky BA; Kehne JH; Schmidt CJ; Sorensen SM; Frank RA
    Pharmacol Biochem Behav; 1998 Feb; 59(2):275-80. PubMed ID: 9476970
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A; Millan MJ
    Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dynamic changes in sensitivity occur during the acute response to cocaine and methylphenidate.
    Kuczenski R; Segal DS
    Psychopharmacology (Berl); 1999 Nov; 147(1):96-103. PubMed ID: 10591874
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Psychopharmacological characterisation of the successive negative contrast effect in rats.
    Phelps CE; Mitchell EN; Nutt DJ; Marston HM; Robinson ES
    Psychopharmacology (Berl); 2015 Aug; 232(15):2697-709. PubMed ID: 25791190
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.
    Takahashi E; Katayama M; Niimi K; Itakura C
    Eur J Pharmacol; 2008 Jul; 589(1-3):149-56. PubMed ID: 18571641
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of monoamine depletion on the ketamine-induced locomotor activity of preweanling, adolescent, and adult rats: Sex and age differences.
    Crawford CA; Moran AE; Baum TJ; Apodaca MG; Montejano NR; Park GI; Gomez V; McDougall SA
    Behav Brain Res; 2020 Feb; 379():112267. PubMed ID: 31593789
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.
    Yamada J; Sugimoto Y
    Brain Res; 2002 Dec; 958(1):161-5. PubMed ID: 12468041
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cocaine-conditioned place preference by dopamine-deficient mice is mediated by serotonin.
    Hnasko TS; Sotak BN; Palmiter RD
    J Neurosci; 2007 Nov; 27(46):12484-8. PubMed ID: 18003826
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effects of dopaminergic/serotonergic reuptake inhibition on maternal behavior, maternal aggression, and oxytocin in the rat.
    Johns JM; Joyner PW; McMurray MS; Elliott DL; Hofler VE; Middleton CL; Knupp K; Greenhill KW; Lomas LM; Walker CH
    Pharmacol Biochem Behav; 2005 Aug; 81(4):769-85. PubMed ID: 15996723
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat.
    Kankaanpää A; Meririnne E; Seppälä T
    Psychopharmacology (Berl); 2002 Feb; 159(4):341-50. PubMed ID: 11823886
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders.
    Winstanley CA; Theobald DE; Dalley JW; Robbins TW
    Neuropsychopharmacology; 2005 Apr; 30(4):669-82. PubMed ID: 15688093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.